report journal article

PDB43 PATIENT REPORTED OUTCOMES ARE SUPERIOR IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LIRAGLUTIDE AS COMPARED TO EXENATIDE, WHEN ADDED TO METFORMIN, SULFONYLUREA OR BOTH

Authors
Publication date
1 May 2009
Publisher
International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1016%2Fs1098-3015%...
      Last time updated on 05/06/2019

      Elsevier - Publisher Connector

      redirect
      oaidoi:10.1016/S1098-3015(10)7358...
      Last time updated on 05/06/2019

      Elsevier - Publisher Connector

      redirect
      oaidoi:10.1016/S1098-3015(10)7358...
      Last time updated on 06/05/2017